Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...
Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...
Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...
Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.
15h
Hosted on MSNScientist adopts natural plant compounds to tackle cancerA Nigerian scientist, Ayomide Adebesin, has said she has made a discovery in cancer treatment by exploring the therapeutic potential of natural plant compounds.In a statement made available to PUNCH ...
3h
Hosted on MSNNxera Pharma Reports Strong Revenue Growth in 2024Sosei Group Corporation ( ($SOLTF) ) has released its Q4 earnings. Here is a breakdown of the information Sosei Group Corporation presented to its ...
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
A team of microbiologists, chemists and pharmaceutical specialists at Shandong University, Guangzhou Medical University, ...
16hon MSN
The government has funded science and then largely left well enough alone. Scientific agencies have been staffed by ...
14hon MSN
Some of the public health websites that the US government was ordered to restore involving gender and gender identity now carry a warning denying the existence of transgender people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results